SCHEMBL7590488

SCHEMBL7590488

Cc1ccccc1-c1ccc(-c2ccc(-c3ccccc3C)s2)s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.60
APP P05067 1/20 0.50
ESR2 Q92731 3/20 0.48
TSHR P16473 2/20 0.43
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
ACHE P22303 1/20 0.43
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
NPC1 O15118 3/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
ESR1 P03372 2/20 0.41
PTPN1 P18031 1/20 0.40
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CTSD P07339 1/20 0.38
BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18696938 0.97 HPGD (0.62) HPGDAPPESR2TSHRHSD17B1
SCHEMBL14417384 0.86 HPGD (0.56) HPGDAPPESR2TSHRHSD17B1
SCHEMBL4146931 0.84 HPGD (0.55) HPGDAPPESR2TSHRHSD17B1
SCHEMBL12365089 0.82 HPGD (0.53) HPGDAPPESR2TSHRHSD17B1
SCHEMBL13250785 0.81 HPGD (0.51) HPGDAPPESR2TSHRHSD17B1
SCHEMBL14515077 0.80 HPGD (0.47) HPGDAPPESR2TSHRHSD17B1
SCHEMBL14515084 0.80 HPGD (0.47) HPGDAPPESR2TSHRHSD17B1
SCHEMBL13282053 0.79 HPGD (0.50) HPGDAPPESR2HSD17B1HSD17B2
SCHEMBL15591320 0.78 APP (0.48) HPGDAPPESR2HSD17B1HSD17B2
SCHEMBL13221494 0.78 HPGD (0.53) HPGDAPPESR2TSHRHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020114973-A1 Molecular compound, luminous material using the same, and luminous element JAPAN CHEMICAL INNOVATION INSTITUTE (JP) 2002-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020114973-A1 Molecular compound, luminous material using the same, and luminous element TYR, BRD4, NOTCH1 HPGD 3513/4885APP 2706/4885ESR2 1935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.